KR100829262B1 - 수컷의 성 기능 부전을 치료하는 방법 - Google Patents

수컷의 성 기능 부전을 치료하는 방법 Download PDF

Info

Publication number
KR100829262B1
KR100829262B1 KR1020047011672A KR20047011672A KR100829262B1 KR 100829262 B1 KR100829262 B1 KR 100829262B1 KR 1020047011672 A KR1020047011672 A KR 1020047011672A KR 20047011672 A KR20047011672 A KR 20047011672A KR 100829262 B1 KR100829262 B1 KR 100829262B1
Authority
KR
South Korea
Prior art keywords
receptor
ejaculation
oxytocin
drug
selective
Prior art date
Application number
KR1020047011672A
Other languages
English (en)
Korean (ko)
Other versions
KR20040079958A (ko
Inventor
네일러앨러스데어마크
러쎌레이첼제인
스트리트스티븐데릭알버트
탱킴-와
반데르그라프피터헤이드위즌
웨이맨크리스토퍼피터
Original Assignee
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드 filed Critical 화이자 인코포레이티드
Publication of KR20040079958A publication Critical patent/KR20040079958A/ko
Application granted granted Critical
Publication of KR100829262B1 publication Critical patent/KR100829262B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
KR1020047011672A 2002-01-31 2003-01-20 수컷의 성 기능 부전을 치료하는 방법 KR100829262B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0202282.0 2002-01-31
GBGB0202282.0A GB0202282D0 (en) 2002-01-31 2002-01-31 Treatment of male sexual dysfunction
PCT/IB2003/000140 WO2003064402A1 (en) 2002-01-31 2003-01-20 Treatment of male sexual dysfunction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020077029747A Division KR20080011232A (ko) 2002-01-31 2003-01-20 수컷의 성 기능 부전을 치료하는 방법

Publications (2)

Publication Number Publication Date
KR20040079958A KR20040079958A (ko) 2004-09-16
KR100829262B1 true KR100829262B1 (ko) 2008-05-13

Family

ID=9930155

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020047011672A KR100829262B1 (ko) 2002-01-31 2003-01-20 수컷의 성 기능 부전을 치료하는 방법
KR1020077029747A KR20080011232A (ko) 2002-01-31 2003-01-20 수컷의 성 기능 부전을 치료하는 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020077029747A KR20080011232A (ko) 2002-01-31 2003-01-20 수컷의 성 기능 부전을 치료하는 방법

Country Status (16)

Country Link
EP (1) EP1470115A1 (ja)
JP (3) JP2005525321A (ja)
KR (2) KR100829262B1 (ja)
CN (1) CN100500658C (ja)
AU (1) AU2003201471B2 (ja)
BR (1) BR0307337A (ja)
CA (1) CA2474590A1 (ja)
GB (1) GB0202282D0 (ja)
HK (1) HK1073109A1 (ja)
IL (2) IL162822A0 (ja)
MX (1) MXPA04007434A (ja)
NZ (1) NZ546408A (ja)
PL (1) PL371415A1 (ja)
TW (1) TW200302732A (ja)
WO (1) WO2003064402A1 (ja)
ZA (1) ZA200405208B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3646871A1 (en) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Treatment and prevention of premature ejaculation (pe)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014438A1 (en) * 1992-12-23 1994-07-07 Merck & Co., Inc. Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0614894A1 (en) * 1993-03-12 1994-09-14 Merck & Co. Inc. Process for the synthesis of substituted amide derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
WO2002003995A2 (en) * 2000-07-06 2002-01-17 Pfizer Limited Treatment of male sexual dysfunction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9114760D0 (en) 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9119704D0 (en) 1991-09-14 1991-10-30 Pfizer Ltd Therapeutic agents
GB9121028D0 (en) 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
GB9126260D0 (en) 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9213623D0 (en) 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
GB9218322D0 (en) 1992-08-28 1992-10-14 Pfizer Ltd Therapeutic agents
GB0007884D0 (en) 2000-03-31 2000-05-17 Pfizer Ltd Diphenyl ether compounds useful in therapy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014438A1 (en) * 1992-12-23 1994-07-07 Merck & Co., Inc. Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0614894A1 (en) * 1993-03-12 1994-09-14 Merck & Co. Inc. Process for the synthesis of substituted amide derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
WO2002003995A2 (en) * 2000-07-06 2002-01-17 Pfizer Limited Treatment of male sexual dysfunction

Also Published As

Publication number Publication date
CA2474590A1 (en) 2003-08-07
JP2010209075A (ja) 2010-09-24
NZ546408A (en) 2007-10-26
KR20040079958A (ko) 2004-09-16
IL162822A (en) 2010-11-30
JP2013151511A (ja) 2013-08-08
MXPA04007434A (es) 2004-10-11
IL162822A0 (en) 2005-11-20
JP2005525321A (ja) 2005-08-25
KR20080011232A (ko) 2008-01-31
ZA200405208B (en) 2005-08-31
WO2003064402A1 (en) 2003-08-07
CN1625553A (zh) 2005-06-08
AU2003201471B2 (en) 2009-03-26
TW200302732A (en) 2003-08-16
CN100500658C (zh) 2009-06-17
BR0307337A (pt) 2004-12-07
HK1073109A1 (en) 2005-09-23
PL371415A1 (en) 2005-06-13
GB0202282D0 (en) 2002-03-20
EP1470115A1 (en) 2004-10-27

Similar Documents

Publication Publication Date Title
KR20030016376A (ko) 남성 성기능 장애의 치료
JP2008266338A (ja) 性機能障害を治療するための選択的ドーパミンｄ３受容体アゴニスト
JP2005350482A (ja) Ｆｓｄの処置のための化合物
US20030119714A1 (en) Treatment of male sexual dysfunction
US20150072995A1 (en) Treatment of male sexual dysfunction
JP2004522720A (ja) 雄性性的機能障害の処置
KR100829262B1 (ko) 수컷의 성 기능 부전을 치료하는 방법
KR100595807B1 (ko) 조루 치료법
AU2003201471A1 (en) Treatment of male sexual dysfunction
JP2004517046A (ja) 医薬
US20040185094A1 (en) Pharmaceutical
KR20030061441A (ko) 남성 성기능 장애의 치료
ZA200304460B (en) Treatment of male sexual dysfunction.
ZA200300120B (en) Treatment of Male sexual dysfunction.

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
AMND Amendment
E801 Decision on dismissal of amendment
B601 Maintenance of original decision after re-examination before a trial
A107 Divisional application of patent
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070227

Effective date: 20080125

S901 Examination by remand of revocation
GRNO Decision to grant (after opposition)
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee